Table: Medrx -2022 group results

Medrx

10/02/2023 06:00

Feb 10 (Reuters)- 
          Medrx.Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to         NEXT     
              Dec 31, 2022    Dec 31, 2021    Dec 31, 2023       YEAR       
                 LATEST         YEAR-AGO         COMPANY         COMPANY    
                 RESULTS         RESULTS        FORECAST       H1 FORECAST  
  Sales          59 mln           8 mln          127 mln         27 mln     
              (+612.4 pct)     (-92.7 pct)    (+214.9 pct)    (+293.7 pct)  
  Operating     loss 1.10       loss 1.06     loss 830 mln    loss 488 mln  
  Recurring     loss 1.11       loss 1.07     loss 783 mln    loss 494 mln  
  Net
  Net           loss 1.11       loss 1.06     loss 786 mln    loss 495 mln  
  EPS        loss 43.81 yen  loss 49.62 yen  loss 27.86 yen  loss 17.56 yen 
  Ann Div          NIL             NIL             NIL                      
  -Q2 Div          NIL             NIL             NIL                      
  -Q4 Div          NIL             NIL             NIL                      
  
  NOTE - Medrx.Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T